Clin2
NCT07232121Likely a fitRecruiting

Safety study of DF5112 in healthy adults

Healthy ParticipantsHealthy Adult FemalesHealthy Adult MaleHealthyVolunteer

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are generally healthy, with no major medical conditions.
  • You haven't had cancer in the last 5 years (except some skin cancers or cervical polyps).
  • You do not have active or chronic infections, including hepatitis, HIV, or tuberculosis.
  • You haven't had a vaccine in the last month and aren't planning one soon.
  • You are not pregnant, nursing, or planning pregnancy during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06616883Not yet recruiting· Phase 1
Study of a new drug in healthy adults

This trial tests how a new drug (DA-5221) works in the body and whether it is safe for healthy adults. If you join, you'll help researchers understand how to dose this medicine for future patients.

Seoul, South Korea
NCT06994897Recruiting· Phase 1
Safety and dosing study of PF-07985631 in healthy adults

This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.

Brussels, Bruxelles-capitale, Région de
NCT06993181Not yet recruiting· Phase 1
Testing a new study drug in healthy adults

This trial tests a new study drug (DA-5222) given alone or with three other components in healthy adults. It helps researchers understand how the drug works in the body and check for any side effects.

Seoul, South Korea
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.